Immuneering Corp (IMRX)
2.17
+0.06
(+2.84%)
USD |
NASDAQ |
Nov 22, 10:43
Immuneering Total Liabilities (Quarterly): 10.84M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.84M |
| June 30, 2024 | 10.78M |
| March 31, 2024 | 9.260M |
| December 31, 2023 | 12.01M |
| September 30, 2023 | 9.863M |
| June 30, 2023 | 9.791M |
| March 31, 2023 | 9.907M |
| December 31, 2022 | 12.52M |
| Date | Value |
|---|---|
| September 30, 2022 | 11.80M |
| June 30, 2022 | 8.455M |
| March 31, 2022 | 8.391M |
| December 31, 2021 | 10.72M |
| September 30, 2021 | 5.749M |
| June 30, 2021 | 88.23M |
| March 31, 2021 | 3.282M |
| December 31, 2020 | 60.90M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.282M
Minimum
Mar 2021
88.23M
Maximum
Jun 2021
17.66M
Average
10.32M
Median
Total Liabilities (Quarterly) Benchmarks
| Singular Genomics Systems Inc | 63.30M |
| Biomarin Pharmaceutical Inc | 1.438B |
| Integra Lifesciences Holdings Corp | 2.544B |
| Eton Pharmaceuticals Inc | 19.86M |
| Tenon Medical Inc | 4.848M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 68.56M |
| Shareholders Equity (Quarterly) | 57.72M |